Effects of stimulant medications on children with attention-deficit/hyperactivity disorder and excessive beta
Adam R Clarke1, Robert J Barry, Rory McCarthy
1Brain and Behaviour Research Institute, University of Wollongong, Wollongong 2522, Australia. adam_clarke@uow.edu.au
Insights
Stimulant medications reduced excessive beta activity in children with attention-deficit/hyperactivity disorder (ADHD), suggesting beta activity is linked to hyperactivity, not inattention. This study offers new insights into ADHD neurophysiology.
Area of Science:
- Neuroscience
- Child Psychology
- Psychopharmacology
Background:
- Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder.
- Children with combined-type ADHD often exhibit excessive beta activity on electroencephalography (EEG).
- Previous theories suggested this beta activity might indicate hypoarousal in ADHD.
Purpose of the Study:
- To investigate the impact of stimulant medications on EEG patterns in children with ADHD and excessive beta activity.
- To clarify the relationship between beta activity, stimulant response, and ADHD symptom domains.
Main Methods:
- Compared EEG recordings from 20 children with ADHD and 20 controls.
- Analyzed EEG data (power bands, ratios) before and after a 6-month stimulant medication trial.
- Utilized Fourier transformation for detailed spectral analysis.
Main Results:
- Unmedicated ADHD group showed higher beta, lower alpha, and altered theta ratios compared to controls.
- ADHD group exhibited increased frontal total power and beta activity.
- Stimulant medication reduced absolute beta activity and frontal power, but did not normalize EEG patterns.
Conclusions:
- Excessive beta activity in ADHD may not signify hypoarousal.
- Beta activity appears associated with impulsivity/hyperactivity, not necessarily inattention.
- This is the first study to examine stimulant effects on EEG in ADHD children with prominent beta activity.
Objective:
This study investigated the effects of stimulant medications on the Electroencephalography (EEG) of children with the combined type of attention-deficit/hyperactivity disorder (ADHD) together with excessive beta activity in their EEG.
Methods:
Twenty ADHD and 20 control subjects participated in this study. EEG was recorded from 21 sites during an eyes-closed resting condition and Fourier transformed to provide estimates for total power and absolute and relative power in the delta, theta, alpha and beta bands, and for the theta/alpha and theta/beta ratios. Subjects were placed on a 6-month trial of a stimulant medication and a second EEG was recorded at the end of the trial.
Results:
The unmedicated ADHD group had greater absolute and relative beta, less absolute and relative alpha, a higher theta/alpha and a lower theta/beta ratio than the control group. In the frontal regions the ADHD group had an increase in total power, absolute theta, absolute and relative beta and the theta/beta ratio, with greater relative delta, relative theta, and absolute and relative alpha in posterior regions. With medication use, absolute beta activity and frontal total power decreased, although these changes represented a reduction in power, not a normalisation.
Conclusions:
These results indicate that ADHD children with excessive beta activity in their EEG are probably not hypoaroused as previously suggested, and that beta activity in these children is probably only associated with the impulsivity and/or hyperactivity aspects of the disorder, but may not necessarily be associated with inattention.
Significance:
This study is the first to investigate effects of stimulant medications on the EEG of ADHD children with excessive beta activity in their EEG.
More Related Videos
Related Concept Videos
01:30Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
01:29Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
01:28Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...